Page 556 - Enfeksiyon Hastalıkları Kitabı

536 Enfeksiyon Hastalıkları

Leblebicioğlu H. Telitromisin. ANKEM Derg 2004;18 (Ek Lok AS, McMahon BJ. Chronic hepatitis B: Update 2009. Hepa-
2):170-173. tology. 2009; 50: 661-662.
Leblebicioğlu H: Diyabetik ayak enfeksiyonu. In: Birol Gülman Lujan M, Gallego M, Rello J. Healthcare-associated infections. A
(Ed) Diyabetik Ayak. 2.Baskı, Samsun, Otak Form Ofset Ba- useful concept?. Curr Opin Crit Care 2009;15:419-424.
sım San ve Tic AŞ. 2001;143-156.
Lujan M, Gallego M, Rello J. Healthcare-associated infections. A
Leblecioğlu H, Usluer G, Ulusoy S. In: Güncel bilgiler ışığında useful concept?. Curr Opin Crit Care 2009;15:419-24.
anti biyotikler. (Yazarlar; Leblecioğlu H, Usluer G, Ulusoy S).
Bilimsel Tıp Yayınevi, Ankara; 2007. Mace SE. Acute bacterial meningitis. Emerg Med Clin N Am
2008;26: 281-317.
Leclerc R. Mechanisms of resistance to macrolides and lincosa-
mides: natures of the resistance elements and their clinical Malik S, Choudhary A, Kumar S, Avasthi G. Quinolones: a the-
implications. Clin Infect Dis 2002; 34:482-492. rapeutic review. J Pharm Res 2010;3:1519-1523.
Leder K, Weller PF. Intestinal tapeworms. www.uptodate.com. Mandal J, Dinoop KP, Parija SC. Increasing antimicrobial re-
08 Ekim 2012. www.uptodate.com/contents/intestinal-tape- sistance of Vibrio cholera O1 Biotype El Tor strains iso-
worms lated in tertiary-care centre in India. J Health Popul Nutr
2012;30:12-16.
Leith J, Piliero P, Storfer S. et al. Appropriate use of nevirapine

for long term therapy. J Infect Dis, 2005;192:545-546. Mandal JVG, Emelde JSM, Parija SC. The recent trens shigello-
sis: A JIPMER perspective. J Clin Diagn Res 2012; 6: 1474-
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ 1477.
ACCP/ATS/SIS International Sepsis Defi nitions Conferen-
ce. Crit Care Med 2003; 31:1250. Mandal S, Mandal MD. Human cystic echinococcosis: epidemi-
ologic, zoonotic, clinical, diagnostic and therapeutic aspects.
Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364:369-79. Asian Pac J Trop Med 2012;5(4): 253-260.

Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Mandell L. Doripenem: a new carbapenem in the treatment of
Duke Criteria fort he diagnosis of infective endocarditis. nosocomial infection. Clin Infect Dis 2009;49 Suppl 1:S1-3.
Clin Infect Dis 2000;30:633-638.
Mandell LA, Wunderink RG, Anzueto A et al. Infectious Disea-
Li SF, Cassidy C, Chang C, Grarib S, Torres J. Diagnostic utility of ses Society of America/American Thoracic Society Consen-

laboratory test in septic arthritis. Emerg Med 2007;24:75-77.
sus Guidelines on the Management of Community-Acqui-
Lievano F, Galea SA, Thornton M, Wiedmann RT, Manoff red Pneumonia in Adults. CID 2007;44:27-72.

SB, Tran TN, Amin MA, Seminack MM, Vagie KA, Dana Marano C, Freedman DO. Global health surveillance and trave-
A, Plotkin SA. Measles, mumps, and rubella virus vaccine lers’ health. Curr Opin Infect Dis 2009; 22:423-429.
(M-M-R™II): A review of 32 years of clinical and postmar-
keting experience. Vaccine. 2012 6;30(48):6918-26. doi: 10. Marano C, Freedman DO. Global health surveillance and trave-
1016/j. lers’ health. Curr Opin Infect Dis 2009; 22:423-429.
Lim LM, Ly N, Anderson D, Yang JC, Macander L, Jarkowski Margatretten ME, Kohlwes J, Moore D, et al. Dose this adult
A, et al. Resurgence of colistin: a review of resistance, to- patient have septic arthritis? JAMA 2007;297:1478-1488.
xicity, pharmacodynamics and dosing. Pharmacotherapy
2010;30:1279-1291. Martin GS, Mannino DM, Eaton S, Moss M. Th e epidemiology
of sepsis in the United States from 1979 through 2000. N
Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern Engl J Med 2003; 348:1546.
DE, Abramson MA: Ertapenem versus piperacillin/tazobac-
tam for diabetic foot infections (SIDESTEP): prospective, Martínez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan
randomised, controlled, double-blinded, multicentre trial. SL. Clindamycin treatment of invasive infections caused by
The Lancet. 2005;366: 1695-1703. community-acquired, methicillin-resistant and methicillin-

susceptible S. aureus in children. Pediatr Infect Dis J. 2003
Lipsky BA, Berendt AR, Cornia PB et al. 2012 Infectious Dise- ;22(7):593-598.
ases Society of America Clinical Practice Guideline for the
Diagnosis and Treatment of Diabetic Foot Infections Clini- Mathews CJ, Coakley G. Septic arthritis: current diagnostic and
cal Infectious Diseases; 2012:54:132-173. therapeutic algorithm. Curr Opin Rheumatol 2008;20:457-
462.
Lipsky BA, Giordano P, Choudhri S, Song J: Treating diabetic
foot infections with sequential intravenous to oral moxif- Mavros M N, Polyzos K A, Rafailidis P I, Falagas M E. Once
loxacin compared with piperacillin–tazobactam/amoxicil- versus multiple daily dosing of aminoglycosides for patients
lin–clavulanate. Journal of Antimicrobial Chemotherapy. with febrile neutropenia: a systematic review and meta-
2007;60:370–376. analysis. J Antimicrob Chemother 2011; 66: 251-259.
Lipsky BA, Itani K, Norden C. Treating foot infections in diabe- Mayhall CG. Hospital epidemiology and infection control. 4.
tic patients: a randomized, multicenter, open-label trial of edition. Lippincott Williams&Wilkins. Philadelphia; 2012.
linezolid versus ampicillin-sulbactam/co-amoxiclav. Clinical
Infectious Diseases. 2004;38: 17–24. McCarter-Spaulding DE. Medications in pregnancy and lactati-
on.MCN Am J Matern Child Nurs. 2005;30(1):10-7.
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by
the infectious diseases society of america for the treatment McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofu-
of methicillin-resistant Staphylococcus aureus infections in rantoin compares favorably to recommended agents as em-
adults and children. Clin Infect Dis. 2011;52(3):18-55. pirical treatment of uncomplicated urinary tract infections
in a decision and cost analysis. Mayo Clin Proc 2011; 86:
Livermore DM. Pseudomonas, porins, pumps and carbapenems. 480-488.
J Antimic Chemother 2001;47:247-50.